NASDAQ: RNAZTranscode Therapeutics Inc Stock Ownership - Who owns Transcode Therapeutics?
Insider buying vs selling
Have Transcode Therapeutics Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when RNAZ insiders and whales buy or sell their stock.
RNAZ Shareholders
What type of owners hold Transcode Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Anna Moore | 186.26% | 1,552,785 | $16.61M | Insider |
| Zdravka Medarova | 186.26% | 1,552,785 | $16.61M | Insider |
| Robert Michael Dudley | 21.62% | 180,262 | $1.93M | Insider |
| Philippe Calais | 15.28% | 127,377 | $1.36M | Insider |
| Thomas A. Fitzgerald | 6.76% | 56,318 | $602.60k | Insider |
| Goldman Sachs Group Inc | 3.36% | 28,042 | $300.05k | Institution |
| Ubs Group Ag | 0.17% | 1,432 | $15.32k | Institution |
| Southstate Corp | 0.06% | 482 | $5.16k | Institution |
| Tower Research Capital LLC Trc | 0.05% | 402 | $4.30k | Institution |
| Sbi Securities Co Ltd | 0.00% | 10 | $107.00 | Institution |
RNAZ vs Biotech Stocks
Transcode Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.